Who Paid My Doc
Rocco Barbieri
Hand Surgery Hattiesburg, MS Medical Doctor
NPI 1942239090 CMS profile 42691
3688 Veterans Memorial Dr, Suite 200, Hattiesburg, MS 39401
General payments
$989
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$1,169
Through program year 2025, Rocco Barbieri of Hattiesburg, MS is reported in the CMS Open Payments database as having received $989 across 23 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,169 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 34th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $504 | 8 | |
| 2024 | General | $102 | 3 | |
| 2023 | General | $59 | 2 | |
| 2022 | General | $86 | 2 | |
| 2021 | General | $102 | 4 | |
| 2019 | General | $137 | 4 |
Beside peers
- Rocco Barbieri
- Hand Surgery median
- Middle half of Hand Surgery
- National median
In program year 2025, general payments to Rocco Barbieri were reported at $504. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.
Show as a table
| Year | Rocco Barbieri | Hand Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $137 | $383 | $106–$1,905 | $163 |
| 2020 | $0 | $172 | $51–$1,268 | $114 |
| 2021 | $102 | $263 | $71–$1,591 | $132 |
| 2022 | $86 | $336 | $87–$1,938 | $149 |
| 2023 | $59 | $233 | $81–$1,114 | $160 |
| 2024 | $102 | $258 | $88–$1,203 | $164 |
| 2025 | $504 | $270 | $102–$1,118 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 14 drugsPart D claims
561
Drug cost
$4,191
Branded share of claims
57.6%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 155 | $1,158 | |
| Ketorolac Tromethamine | Generic | 66 | $1,022 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 112 | $617 | |
| Celecoxib | Generic | 29 | $332 | |
| Gabapentin | Generic | 28 | $277 | |
| Ondansetron Odt Ondansetron | Brand | 22 | $190 | |
| Clindamycin Hcl | Generic | 12 | $163 | |
| Methylprednisolone | Generic | 21 | $134 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 34 | $85 | |
| Ondansetron Hcl | Generic | 24 | $76 |
The 10 drugs with the highest cost, of 14 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 139 billing codesPaid by Medicare
$228,781
Medicare patients
699
Services billed
19,024
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Ischemic heart disease | 37% | |
| Diabetes | 32% | |
| Depression | 28% | |
| Chronic kidney disease | 19% | |
| Osteoporosis | 17% | |
| COPD | 15% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, methylprednisolone acetate, 1 mg J1010 | Office | 221 | 15,835 | $1,593 |
| Injection, methylprednisolone acetate, 40 mg J1030 | Office | 84 | 109 | $347 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
23 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hand Surgery in Mississippi
Related records
Hand Surgery in Mississippi
Practitioners in the same specialty and state, ranked by reported value.
All Hand Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Mississippi
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.